U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

(Reuters) -The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health ...

Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in ...

Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class ...

WASHINGTON — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and ...

Along with claiming the lives of 1.2 million Americans, the COVID-19 pandemic has been described as a mass disabling event.

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

Several of Donald Trump’s picks for his Cabinet and key roles in his administration are facing confirmation hearings in the Senate today as the president continues to implement executive actions to ...

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...